A phase II study of adjuvant chemoradiation with weekly oxaliplatin in patients with high risk resected squamous cell carcinoma of the head and neck region

Trial Profile

A phase II study of adjuvant chemoradiation with weekly oxaliplatin in patients with high risk resected squamous cell carcinoma of the head and neck region

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 11 May 2010

At a glance

  • Drugs Oxaliplatin (Primary)
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 May 2010 Planned end date changed from 1 Dec 2008 to 1 Dec 2010 as reported by ClinicalTrials.gov.
    • 12 Dec 2008 Status changed from recruiting to active, no longer recruiting.
    • 23 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top